Yi Zhao

148 total papers · 1.2k total citations
86 papers, 765 citations indexed

About

Yi Zhao is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Yi Zhao has authored 86 papers receiving a total of 765 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 26 papers in Hematology and 24 papers in Molecular Biology. Recurrent topics in Yi Zhao's work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Yi Zhao is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Yi Zhao collaborates with scholars based in China, United States and Sweden. Yi Zhao's co-authors include Zhen Cai, Jingsong He, Donghua He, Yue Zhang, Yin Wang, Peifeng Li, Bingqiang Zhang, Kai Zheng, Li Yang and Gaofeng Zheng and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Yi Zhao

71 papers receiving 750 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yi Zhao 279 174 145 114 82 86 765
Tae Young Kim 206 0.7× 138 0.8× 89 0.6× 150 1.3× 35 0.4× 39 794
Shirong Li 221 0.8× 120 0.7× 56 0.4× 66 0.6× 67 0.8× 58 898
Xiangyuan Liu 156 0.6× 105 0.6× 78 0.5× 136 1.2× 40 0.5× 66 808
Junwei Huang 454 1.6× 139 0.8× 62 0.4× 49 0.4× 41 0.5× 44 745
Tingting Lu 267 1.0× 83 0.5× 55 0.4× 66 0.6× 28 0.3× 51 694
Tong Xiao 285 1.0× 69 0.4× 70 0.5× 190 1.7× 55 0.7× 47 755
A. Nilsson 399 1.4× 57 0.3× 123 0.8× 168 1.5× 35 0.4× 32 848
Shashi Kant Verma 218 0.8× 82 0.5× 21 0.1× 88 0.8× 61 0.7× 58 801
Changhong Yin 268 1.0× 119 0.7× 119 0.8× 62 0.5× 80 1.0× 59 732
Tsutomu Yamada 132 0.5× 78 0.4× 86 0.6× 48 0.4× 16 0.2× 78 682

Countries citing papers authored by Yi Zhao

Since Specialization
Citations

This map shows the geographic impact of Yi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhao more than expected).

Fields of papers citing papers by Yi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhao. The network helps show where Yi Zhao may publish in the future.

Co-authorship network of co-authors of Yi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhao. A scholar is included among the top collaborators of Yi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhao. Yi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026